Cargando…

Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?

OBJECTIVES: We assessed cumulative incidence rates of and factors associated with re-engagement in HIV care for PLHIV lost to follow-up in Mali. METHODS: HIV-1-infected individuals lost to follow-up before 31/12/2013, ≥ 18 years old, who started ART from 2006 to 2012 at one of 16 care centres were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldé, Aliou, Lièvre, Laurence, Maiga, Almoustapha Issiaka, Diallo, Fodié, Maiga, Issouf Alassane, Costagliola, Dominique, Abgrall, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482938/
https://www.ncbi.nlm.nih.gov/pubmed/32911516
http://dx.doi.org/10.1371/journal.pone.0238687
_version_ 1783580874163355648
author Baldé, Aliou
Lièvre, Laurence
Maiga, Almoustapha Issiaka
Diallo, Fodié
Maiga, Issouf Alassane
Costagliola, Dominique
Abgrall, Sophie
author_facet Baldé, Aliou
Lièvre, Laurence
Maiga, Almoustapha Issiaka
Diallo, Fodié
Maiga, Issouf Alassane
Costagliola, Dominique
Abgrall, Sophie
author_sort Baldé, Aliou
collection PubMed
description OBJECTIVES: We assessed cumulative incidence rates of and factors associated with re-engagement in HIV care for PLHIV lost to follow-up in Mali. METHODS: HIV-1-infected individuals lost to follow-up before 31/12/2013, ≥ 18 years old, who started ART from 2006 to 2012 at one of 16 care centres were considered. Loss to follow-up (LTFU) was defined as an interruption of ≥ 6 months during follow-up. The re-engagement in care in PLHIV lost to follow-up before 31/12/2013 was defined as having at least one clinical visit after LTFU. The cumulative incidence rates of re-engagement in care was estimated by Kaplan-Meier and its predictive factors were assessed using Cox models. Socio-demographic characteristics, clinical and immune status, period, region, centre expertise level, and distance from home at the start of ART plus a combined variable of duration of ART until LTFU and 12-month change in CD4 count were assessed. Multiple imputation was used to deal with missing data. RESULTS: We included 3,650 PLHIV lost to follow-up before December 2013, starting ART in nine outpatient clinics and seven hospitals (5+2 in Bamako and 4+5 in other regions): 35% male, median (IQR) age 35 (29–43), and duration of ART until LTFU 11 months (5–22). Among these PLHIV, 1,975 (54%) were definitively LTFU and 1,675 (46%) subsequently returned to care. The cumulative incidence rates of re-engagement in care rose from 39.0% at one year to 47.0% at three years after LTFU. Predictors of re-engagement in care were starting ART with WHO stage 1–2 and CD4 counts ≥ 200 cells/μL, being treated for ≥ 12 months with CD4 count gain ≥ 50 cells/μL, or being followed in Bamako. People followed at regional hospitals or outpatient clinics ≥ 5 km away, or being treated for ≥ 12 months with CD4 count gain < 50 cells/μL were less likely to return to care. CONCLUSIONS: Starting ART with a higher CD4 count, better gain in CD4 count, and being followed either in Bamako or close to home in the regions were associated with re-engagement in care.
format Online
Article
Text
id pubmed-7482938
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74829382020-09-21 Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care? Baldé, Aliou Lièvre, Laurence Maiga, Almoustapha Issiaka Diallo, Fodié Maiga, Issouf Alassane Costagliola, Dominique Abgrall, Sophie PLoS One Research Article OBJECTIVES: We assessed cumulative incidence rates of and factors associated with re-engagement in HIV care for PLHIV lost to follow-up in Mali. METHODS: HIV-1-infected individuals lost to follow-up before 31/12/2013, ≥ 18 years old, who started ART from 2006 to 2012 at one of 16 care centres were considered. Loss to follow-up (LTFU) was defined as an interruption of ≥ 6 months during follow-up. The re-engagement in care in PLHIV lost to follow-up before 31/12/2013 was defined as having at least one clinical visit after LTFU. The cumulative incidence rates of re-engagement in care was estimated by Kaplan-Meier and its predictive factors were assessed using Cox models. Socio-demographic characteristics, clinical and immune status, period, region, centre expertise level, and distance from home at the start of ART plus a combined variable of duration of ART until LTFU and 12-month change in CD4 count were assessed. Multiple imputation was used to deal with missing data. RESULTS: We included 3,650 PLHIV lost to follow-up before December 2013, starting ART in nine outpatient clinics and seven hospitals (5+2 in Bamako and 4+5 in other regions): 35% male, median (IQR) age 35 (29–43), and duration of ART until LTFU 11 months (5–22). Among these PLHIV, 1,975 (54%) were definitively LTFU and 1,675 (46%) subsequently returned to care. The cumulative incidence rates of re-engagement in care rose from 39.0% at one year to 47.0% at three years after LTFU. Predictors of re-engagement in care were starting ART with WHO stage 1–2 and CD4 counts ≥ 200 cells/μL, being treated for ≥ 12 months with CD4 count gain ≥ 50 cells/μL, or being followed in Bamako. People followed at regional hospitals or outpatient clinics ≥ 5 km away, or being treated for ≥ 12 months with CD4 count gain < 50 cells/μL were less likely to return to care. CONCLUSIONS: Starting ART with a higher CD4 count, better gain in CD4 count, and being followed either in Bamako or close to home in the regions were associated with re-engagement in care. Public Library of Science 2020-09-10 /pmc/articles/PMC7482938/ /pubmed/32911516 http://dx.doi.org/10.1371/journal.pone.0238687 Text en © 2020 Baldé et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Baldé, Aliou
Lièvre, Laurence
Maiga, Almoustapha Issiaka
Diallo, Fodié
Maiga, Issouf Alassane
Costagliola, Dominique
Abgrall, Sophie
Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
title Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
title_full Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
title_fullStr Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
title_full_unstemmed Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
title_short Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
title_sort re-engagement in care of people living with hiv lost to follow-up after initiation of antiretroviral therapy in mali: who returns to care?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482938/
https://www.ncbi.nlm.nih.gov/pubmed/32911516
http://dx.doi.org/10.1371/journal.pone.0238687
work_keys_str_mv AT baldealiou reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare
AT lievrelaurence reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare
AT maigaalmoustaphaissiaka reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare
AT diallofodie reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare
AT maigaissoufalassane reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare
AT costaglioladominique reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare
AT abgrallsophie reengagementincareofpeoplelivingwithhivlosttofollowupafterinitiationofantiretroviraltherapyinmaliwhoreturnstocare